ArticlePloS one2025
Multi-cancer analysis of histopathologic MSI screening based on digital histology image.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence and Digital Pathology for Molecular Classification of Endometrial Cancer.International journal of molecular sciences · 2026Review
- Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers.International journal of molecular sciences · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microsatellite instability, a genetic indication of DNA mismatch impairment, provides promising treatment options. Our study aimed to detect the mutation with whole-slide image (WSI) and discover the most effective pre-trained deep-learning model to sort diagnostic slides between high microsatellite instability (MSI-H) and microsatellite stable (MSS). WSI data retrieved from public dataset were processed for training and evaluating MSI categorization model. We detected MSI in slide levels for colorectal cancer (CRC), stomach adenocarcinoma (STAD), uterine corpus, and endometrial adenocarcinoma (UCEC). Models trained with a single tissue type were evaluated with the test dataset of corresponding tissue and subsequently with the test dataset of other types of tissue (cross-tissue evaluation). Finally, another model trained with multi-tissue types was built to predict the test dataset of individual tissue. Our models achieved AUC values of 0.93, 0.84, and 0.79 in TCGA-CRC, TCGA-STAD and TCGA-UCEC, respectively. We observed that a model trained on a corresponding tumor tissue demonstrates higher accuracy, particularly compared to those trained on other tumor tissues. In the combined model trained on multi-tissue, we observed diverse outcomes regarding which model was prioritized depending on the cancer type. These results demonstrate that models trained on multiple tissues have the potential to discern features that are generalizable across different types of cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.